Serological viral testing of cadaveric cornea donors

Transplantation

Volumn 82, Issue 6, 2006, Pages 788-793

  Challine, Dominique ^a   Roudot Thoraval, Françoise ^a   Sabatier, Patrick ^b   Dubernet, Fabienne ^a   Larderie, Patrick ^a   Rigot, Pierrette ^a   Pawlotsky, Jean Michel ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b Banque Française des Yeux   (France)

Author keywords

Cornea; Serological testing; Transplantation; Viral risk

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CADAVER; CADAVER DONOR; CONTROLLED STUDY; CORNEA; CORNEA TRANSPLANTATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOASSAY; MALE; PRIORITY JOURNAL; SEROLOGY; VIRUS CHARACTERIZATION; VIRUS STRAIN;

CADAVER; CORNEA; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LIVING DONORS; TISSUE DONORS;

EID: 33749138225     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000236572.27197.08     Document Type: Article

References (20)

1. Hoft RH, Pflugfelder SC, Forster RK, et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea 1997; 16: 132.
2. Eastlund T. Infection disease transmission through cell, tissue and organ transplantation: reducing the risk through donor selection. Cell Transplantation 1995; 4: 455.
3. Tjabbes H. Donor screening: an overview of current regulation and practices in Europe. Transplantation Proceedings 1996; 28: 2950.
4. Eastlund T. Hemodilution due to blood loss and transfusion and reliability of cadaver tissue donor infectious disease testing. Cell and Tissue Banking 2000; 1: 121.
5. Heim A, Wagner D, Rothamel T, Hartmann U, Flik J, et al. On of serological screening of cadaveric sera for donor selection for cornea transplantation. Journal of Medical Virology 1999; 58: 291.
6. Estimation des taux de prévalence des anticorps anti-VHC et des marqueurs du virus de l'hépatite B chez les assurés sociaux du régime général de France métropolitaine, 2003-2004. Institut National de Veille Sanitaireqq, January 2005.
7. Desenclos J-C, Costagliola D, Commenges D, et al. La prévalence de la séropositivité VIH en France. Bulletin Epidémiologique Hebdomadaire 2005; 11: 41-44.
8. Chung CW, Rapuano CJ, Laibson PR, et al. Human immunodeficiency virus p24 antigen testing in cornea donors. Cornea 2001; 20: 277.
9. Miedouge M, Chatelut M, Mansuy JM, et al. Screening of blood from potential organ and cornea donors for viruses. Journal of Medical Virology 2002; 66: 571.
10. Stanworth SJ, Warwick RM, Ferguson M, et al. A UK survey of virological testing of cadaver tissue donors. Vox Sanguinis 2000; 79: 227.
11. Laycock KA, Essary LR, Delaney S, et al. A critical evaluation of hepatitis C testing of cadaveric corneal donors. Cornea 1997; 16: 146.
12. Cahane M, Bark A, Goller O, et al. The incidence of hepatitis C virus positive serological test results among cornea donors. Cell and Tissue Banking 2000; 1: 81.
13. European Eye Bank association. Agreement on minimum standards. www.europeaneyebanks.org.
14. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology 2002; 122: 1564.
15. Tabor E, Epstein JS. NAT screening of blood and plasma donations: evolution of technology and regulatory policy. Transfusion 2002; 42: 1230.
16. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351: 760.
17. Challine D, Pellegrin B, Bouvier-Alias M, et al. HIV and hepatitis C virus RNA in seronegative organ and tissue donoes. Lancet 2004; 364: 1611-1612.
18. Tugwell BD, Patel PR, Williams IT, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143: 648.
19. Chevaliez S, Challine D, Brillet R, et al. Full-length preS1-preS2-HBs antigen (HBsAg) sequence analysis of HBV surface mutants in HBV DNA-positive organ, tissue and cell donors with various HBV serological profiles. J Hepatol 2006; 44(suppl. 2): S22.
20. Strong DM, Nelson K, Pierce M, et al. Preventing disease transmission by deceased tissue donors by testing blood for viral nucleic acid. Cell Tissue Bank 2005; 6: 255.